The association of perceived cannabis risks and benefits with cannabis use since cancer diagnosis

Author:

McDaniels-Davidson Corinne12ORCID,Parada Jr Humberto23,Kasiri Nasim3,Patel Sandip P2,Strong David24,Doran Neal256

Affiliation:

1. Division of Health Promotion and Behavioral Science, School of Public Health, San Diego State University , San Diego, CA, USA

2. Moores Cancer Center at UC San Diego Health , La Jolla, CA, USA

3. Division of Epidemiology and Biostatistics, School of Public Health, San Diego State University , San Diego, CA, USA

4. Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego ,La Jolla, CA, USA

5. Department of Psychiatry, School of Medicine, University of California, San Diego , La Jolla, CA, USA

6. Psychology Service, Jennifer Moreno Department of Veterans Affairs Medical Center , San Diego, CA, USA

Abstract

Abstract Background Many patients with cancer use cannabis to help alleviate untreated cancer symptoms and side effects. Methods We examined associations of perceived benefits and risks and postdiagnosis cannabis use in a weighted sample of adult cancer survivors through a 1-time survey. Fifteen perceived cannabis use benefits and 19 perceived risks were operationalized as both summary scores and report of any benefits or risks. Survey-weighted logistic regression provided covariate-adjusted odds of postdiagnosis cannabis use for each benefit-risk measure. Results Among the weighted population of 3785 survivors (mean [SD] age = 62.2 [13.5] years), one-third used cannabis after diagnosis. Perceiving any benefits increased the odds of postdiagnosis cannabis use more than 500%, and perceiving any risks lowered the odds by 59%. Each SD increase in endorsed benefits doubled the odds of postdiagnosis cannabis use, while each SD increase in endorsed risks reduced the odds by 36%. Conclusion An accurate understanding of benefits and risks is critical for informed decision making.

Funder

NCI

San Diego State University FUERTE

San Diego State University

University of California, San Diego Comprehensive Cancer Partnership

UCSD Moores Cancer Center Support

San Diego Alzheimer’s Disease Resource Center for Minority Aging Research

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3